We report biochemical data on a child with MSUD who underwent peritoneal dialysis for severe metabolic imbalance. In confirmation of earlier data, the BCKA/BCAA ratios in blood had been found to be fairly stable in this patient during long-term dietary therapy.
The child became comatose at comparatively low levels of leucine and KICA (ca. 2 mM each). At this time the blood/cerebrospinal fluid ratio for BCAA's and BCKA's was markedly diminished. During peritoneal dialysis, peritoneal clearance was highest for KIVA, but less for MEVA and BCAA's (40–50% or urea clearance), and least for the allegedly most toxic metabolite, KICA. The differences for BCKA's may be due to their differential protein binding. Given these individual differences, 1.8 to 8.7 initial plasma volumes were cleared in 14h with 24.21 of dialysis fluid. In the same time, urinary excretion of BCAA's and BCKA's was much less efficient.
The data are discussed with regard to the pathobiochemical significance of high tissue levels of branched chain acids. A quantitative comparison between peritoneal dialysis and exchange transfusion is not yet possible.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
- BCAA's :
branched-chain α-amino acids
- BCKA's :
branched-chain α-keto acids
- KICA :
- KIVA :
- MEVA :
- MSUD :
maple syrup urine disease
Astine, J., Froye, E., Luciani, J.-M., Bellet, H., de Bornier, P. M., Brunel, D.: Leucinose néo-natale d'évolution favorable. Problèmes évolutives et thérapeutiques. Ann. Pédiat. 24, 605–610 (1977)
Benson, J. V., Cormick, J., Patterson, J. A.: Accelerated chromatography of aminoacids associated with phenylketonuria, leucinosis (maple syrup urine disease) and other inborn errors of metabolism. Anal. Biochem. 18, 481–492 (1967)
Boen, S. T.: Peritoneal dialysis in clinical medicine. Springfield, Ill.: Thomas 1964
Bulla, M.: Dialyse im Kindesalter. Stuttgart: Enke 1977
Dancis, J., Hutzler, J., Lewitz, M.: Metabolism of the white blood cells in maple syrup urine disease. Biochim. Biophys. Acta 43, 342–343 (1960)
Dent, C. E., Westall, R. G.: Studies in maple syrup urine disease. Arch. Dis. Child. 36, 259–268 (1961)
Dreyfus, P. M., Prensky, A. L.: Further observations on the biochemical lesion in maple syrup urine disease. Nature 214, 276 (1967)
Gaull, G. E.: Pathogenesis of maple syrup urine disease: Observation during dietary management and treatment of coma by peritoneal dialysis. Biochem. Med. 3, 130–149 (1969)
Gaull, G. E., Tallan, H. H., Lajtha, A., Rassin, D. K.: Pathogenesis of brain dysfunction in inborn errors of amino acid metabolism. In: Biology of brain dysfunction, Vol. 3, G. E. Gaull (ed.). New York, London: Plenum 1975
Hammersen, G., Wille, L., Schmidt, H., Lutz, P., Bickel, H.: Maple syrup urine disease: Treatment of the acutely ill newborn. Eur. J. Pediatr. 129, 157–165 (1978)
Harris, R. J.: Infection in maple-syrup urine disease. Lancet 1971 II, 813–814
Humoller, F. L., Mahler, D. J., Parker, M. M.: Distribution of amino acids between plasma and spinal fluid. Int. J. Neuropsych. 2, 293–297 (1966)
Lancaster, G., Mamer, O. A., Scriver, C. R.: Branched-chain alpha-keto acids isolated as oxime derivatives: Relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease. Metabolism 23, 257–265 (1974)
Langenbeck, U., Hoinowski, A., Mantel, K., Mehring, H.-U.: Quantitative gaschromatography and single-ion detection of aliphatic α-keto acids from urine as their o-trimethylsilyl quinoxalinol derivatives. J. Chromatogr. 143, 39–50 (1977)
Langenbeck, U., Matthaei, D.: Unpublished observations, 1979
Langenbeck, U., Wendel, U., Luthe, H.: Renal clearance of branched-chain 2-oxo-acids in maple syrup urine disease. J. Clin. Chem. Clin. Biochem. 17, 176–177 (1979)
Langenbeck, U., Wendel, U., Mench-Hoinowski, A., Kuschel, D., Becker, K., Przyrembel, H., Bremer, H. J.: Correlations between branched-chain amino acids and branched-chain α-keto acids in blood in maple syrup urine disease. Clin. Chim. Acta 88, 283–291 (1978)
Rapoport, S. J.: Blood-brain barrier in physiology and medicine. New York: Raven Press 1976
Rey, F., Rey, J., Cloup, M., Féron, J.-F., Doré, F., Labrune, B., Frézal, J.: Traitement d'urgence d'une forme aigue de leucinose par dialyse peritoneale. Arch. Franç. Pédiat. 26, 133–137 (1969)
Sallan, S. E., Cottom, D.: Peritoneal dialysis in maple syrup urine disease. Lancet 1969 II, 1423–1424
Saudubray, J.-M., Fournet, J.-P., Cloup, M.: Intérêt de la dialyse péritonéale dans le traitement d'urgence des maladies métaboliques d'origine constitutionelle révélées dans la période néo-natale. Ann. Méd. interne 122, 1279–1283 (1971)
Schauder, P., Matthaei, D., Scheler, F., Mench-Hoinowski, A., Langenbeck, U.: Blood levels of branched-chain α-keto acids in uremia: therapeutic implication. Klin. Wochenschr. 57, 825–830 (1979)
Schuchmann, L., Witt, I., Schulz, P., Schuhmacher, H., Rüdiger, H. W.: Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease. Helv. Paediat. Acta 27, 449–456 (1972)
Scriver, C. R., Rosenberg, L. E.: Amino acid metabolism and its disorders, pp. 54–56. Philadelphia: Saunders 1973
Snyderman, S. E., Norton, P. M., Roitman, E., Holt, L. E., Jr.: Maple syrup urine disease with particular reference to dieto-therapy. Pediatrics 34, 454–472 (1964)
With support of the Landesamt für Forschung des Ministeriums für Wissenschaft und Forschung des Landes Nordrhein-Westfalen. U.L. was supported by Deutsche Forschungsgemeinschaft, Bad Godesberg, G.F.R. (DFG La 201, Schwerpunkt “Biochemische Humangenetik” and SFB 33 “Nervensystem und biologische Information”)
About this article
Cite this article
Wendel, U., Becker, K., Przyrembel, H. et al. Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr 134, 57–63 (1980). https://doi.org/10.1007/BF00442404
- Maple syrup urine disease
- Peritoneal dialysis
- Peritoneal clearances
- Branched-chain α-amino acids
- Branched-chain α-keto acids